Patents by Inventor Joseph Jardine

Joseph Jardine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230357364
    Abstract: The present application is directed to recombinant monoclonal antibodies, or antigen fragments thereof that bind a Spike protein of SARS-CoV-2. Methods of using the antibodies to treat or prevent SARS-CoV-2 (COVID-19) are also disclosed.
    Type: Application
    Filed: May 6, 2021
    Publication date: November 9, 2023
    Inventors: Devin Sok, Joseph Jardine, Elise Landais, Dennis Burton, Tom Rogers, Fangzhu Zhao, Deli Huang
  • Patent number: 11418475
    Abstract: In embodiments, an apparatus for computing may include a receiver; a speaker; circuitry coupled to the receiver and speaker; and a service to be operated by the circuitry to receive an instance of a message via the receiver, and to conditionally affect a provision, through the speaker, an audio notification alert of the receipt of the instance of the message. In embodiments, to conditionally affect the provision may include to bypass or cause to bypass of the provision of the audio notification alert, on determination that another audio notification alert has been or will be provided by another proximally located apparatus for receiving another instance of the same message. Other embodiments may be described and claimed.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: August 16, 2022
    Assignee: Intel Corporation
    Inventors: Mike Hibbett, Jelle Seis, Joseph Jardine, William Rafferty, Diarmaid O'Cualain
  • Patent number: 11248027
    Abstract: The present invention relates to engineered outer domain (eOD) immunogens of HIV gp120 and mutants thereof and methods of making and using the same. The present invention also includes fusions of eOD to various protein multimers to enhance immunogenicity. The mutant eODs bind to neutralizing antibody precursors. The mutant eODs can activate germline precursors on the pathway to eliciting a broadly neutralizing antibody (bnAb) response. The invention also relates to immunized knock-in mice expressing germline-reverted heavy chains. Induced antibodies showed characteristics of bnAbs and mutations that favored binding to near-native HIV-1 gp120 constructs. In contrast, native-like immunogens failed to activate precursors. The invention also relates to rational epitope design that can prime rare B cell precursors for affinity maturation to desired targets.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: February 15, 2022
    Assignees: INTERNATIONAL AIDS VACCINE INITIATIVE, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: William Schief, Sergey Menis, Daniel Kulp, Joseph Jardine
  • Publication number: 20210292396
    Abstract: The present disclosure relates to anti-HIV Env antibodies and their use in the treatment or prevention of HIV/AIDS.
    Type: Application
    Filed: July 26, 2019
    Publication date: September 23, 2021
    Inventors: Devin SOK, Joseph JARDINE
  • Publication number: 20210051128
    Abstract: In embodiments, an apparatus for computing may include a receiver; a speaker; circuitry coupled to the receiver and speaker; and a service to be operated by the circuitry to receive an instance of a message via the receiver, and to conditionally affect a provision, through the speaker, an audio notification alert of the receipt of the instance of the message. In embodiments, to conditionally affect the provision may include to bypass or cause to bypass of the provision of the audio notification alert, on determination that another audio notification alert has been or will be provided by another proximally located apparatus for receiving another instance of the same message. Other embodiments may be described and claimed.
    Type: Application
    Filed: November 4, 2020
    Publication date: February 18, 2021
    Inventors: Mike Hibbett, Jelle Sels, Joseph Jardine, William Rafferty, Diarmaid O'Cualain
  • Patent number: 10862846
    Abstract: In embodiments, an apparatus for computing may include a receiver; a speaker; circuitry coupled to the receiver and speaker; and a service to be operated by the circuitry to receive an instance of a message via the receiver, and to conditionally affect a provision, through the speaker, an audio notification alert of the receipt of the instance of the message. In embodiments, to conditionally affect the provision may include to bypass or cause to bypass of the provision of the audio notification alert, on determination that another audio notification alert has been or will be provided by another proximally located apparatus for receiving another instance of the same message. Other embodiments may be described and claimed.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: December 8, 2020
    Assignee: Intel Corporation
    Inventors: Mike Hibbett, Jelle Sels, Joseph Jardine, William Rafferty, Diarmaid O'Cualain
  • Publication number: 20190044905
    Abstract: In embodiments, an apparatus for computing may include a receiver; a speaker; circuitry coupled to the receiver and speaker; and a service to be operated by the circuitry to receive an instance of a message via the receiver, and to conditionally affect a provision, through the speaker, an audio notification alert of the receipt of the instance of the message. In embodiments, to conditionally affect the provision may include to bypass or cause to bypass of the provision of the audio notification alert, on determination that another audio notification alert has been or will be provided by another proximally located apparatus for receiving another instance of the same message. Other embodiments may be described and claimed.
    Type: Application
    Filed: May 25, 2018
    Publication date: February 7, 2019
    Inventors: Mike Hibbett, Jelle Sels, Joseph Jardine, William Rafferty, Diarmaid O'Cualain
  • Publication number: 20180194809
    Abstract: The present invention relates to engineered outer domain (eOD) immunogens of HIV gp120 and mutants thereof and methods of making and using the same. The present invention also includes fusions of eOD to various protein multimers to enhance immunogenicity. The mutant eODs bind to neutralizing antibody precursors. The mutant eODs can activate germline precursors on the pathway to eliciting a broadly neutralizing antibody (bnAb) response. The invention also relates to immunized knock-in mice expressing germline-reverted heavy chains. Induced antibodies showed characteristics of bnAbs and mutations that favored binding to near-native HIV-1 gp120 constructs. In contrast, native-like immunogens failed to activate precursors. The invention also relates to rational epitope design that can prime rare B cell precursors for affinity maturation to desired targets.
    Type: Application
    Filed: December 18, 2017
    Publication date: July 12, 2018
    Inventors: William Schief, Sergey Menis, Daniel Kulp, Joseph Jardine